2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Comparative efficacy of preprandial or postprandial humalog® mix75/25™ versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus

      , , , , , ,
      Clinical Therapeutics
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Humalog Mix75/25 (Mix75/25) is a novel premixed insulin containing 75% neutral protamine lispro (an intermediate-acting insulin) and 25% insulin lispro.

          Related collections

          Author and article information

          Journal
          Clinical Therapeutics
          Clinical Therapeutics
          Elsevier BV
          01492918
          January 2002
          January 2002
          : 24
          : 1
          : 73-86
          Article
          10.1016/S0149-2918(02)85006-8
          11833837
          908fe75a-832a-4656-a2b1-d58283bc6e32
          © 2002

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article